CNS Pharmaceuticals regains Nasdaq bid price compliance after 20-day period

CNS Pharmaceuticals, Inc.

Received Nasdaq deficiency letter Feb 27, 2024 for bid price below $1.00 for 30 consecutive days.
On July 5, 2024, Nasdaq confirmed compliance as closing bid price ≥ $1.00 for 20 consecutive business days (June 5 – July 3, 2024).
Matter is closed; company continues listing on Nasdaq Capital Market under ticker CNSP.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.